Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
Namrata Singh, Consultant Pathologist at Metropolis Global Reference Lab., shared a post on LinkedIn about a recent article by Nicole M. Pietras et al., published in National Library of Medicine, adding:
“Beyond Low Platelets: Understanding What Triggers Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP) is often perceived as simply a condition of low platelet counts, but its causes are far more complex.
Understanding the underlying triggers is essential for accurate diagnosis and effective management.
Common Triggers of ITP
1. Infections: Many cases of ITP are preceded by viral infections. Through a mechanism known as molecular mimicry, antibodies produced against viral antigens may mistakenly attack platelet antigens.
Commonly associated infections include:
- HIV
- Hepatitis C virus (HCV)
- Cytomegalovirus (CMV)
- Varicella-zoster virus (VZV)
2. Autoimmune Disorders Loss of immune tolerance can lead to the production of autoantibodies targeting platelets.
Conditions frequently associated with ITP:
- Systemic Lupus Erythematosus (SLE)
- Antiphospholipid Syndrome (APS)
- Evans Syndrome
- Common Variable Immunodeficiency (CVID)
- Autoimmune Lymphoproliferative Syndrome (ALPS)
- Post-hematopoietic stem cell transplantation
3. Drug-Induced Thrombocytopenia Several medications can trigger immune-mediated platelet destruction.
Important examples include:
- Heparin
- Quinine
- Vancomycin
- Linezolid
- Rifampicin
- Carbamazepine
- Phenytoin
- Sulfonamides
- β-lactam antibiotics
- Trimethoprim-sulfamethoxazole
4. Vaccination-Associated Cases Rarely, ITP has been reported following MMR vaccination, particularly in children.
5. Malignancies Secondary ITP may occur in association with:
- Chronic Lymphocytic Leukemia (CLL)
- Lymphomas
- Adenocarcinomas
6. Endocrine Disorders Autoimmune endocrine diseases such as:
- Hypothyroidism
- Addison’s disease
May occasionally be associated with thrombocytopenia.
Clinical Pearl:
ITP remains a diagnosis of exclusion. Identifying secondary causes is crucial because treating the underlying condition may significantly improve platelet counts and patient outcomes.
When evaluating a patient with isolated thrombocytopenia, always think beyond ‘primary ITP’ and actively search for infections, autoimmune disorders, medications, malignancies, and endocrine diseases.”
Title: Immune Thrombocytopenia
Authors: Nicole M. Pietras, Nagendra Gupta, Angel A. Justiz Vaillant, Anthony L. Pearson-Shaver

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation